Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shaklai

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|February 21, 1992
Novel anticancer prodrugs of butyric acid. 2A Nudelman, M Ruse, A Aviram, et al.
Leukemia & Lymphoma|April 8, 1999
Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patientsA Aviram, D Blickstein, P Stark, et al.
British Journal of Cancer|June 28, 2002
Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphomaI Pazgal, Y Zimra, C Tzabar, et al.
The American Journal of Digestive Diseases|March 1, 1974
Intestinal lymphoma with unusual sequence of serum IgA changesM Shaklai, U Mintz, J Pinkhas, et al.
Scandinavian Journal of Haematology|April 1, 1982
Absence of predictive parameters for CNS involvement in adult non-lymphocytic leukaemia at time of diagnosisY Shoenfeld, M Rothenberg, S Berliner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cellsA Aviram, A Rephaeli, M Shaklai, et al.
Cancer|July 15, 1984
Monoclonal gammopathy in patients with chronic and acute myeloid leukemiaY Shoenfeld, S Berliner, A Ayalone, et al.
Journal of Clinical Gastroenterology|April 25, 2000
Pernicious anemia, gastric carcinoid, and autoimmune thrombocytopenia in a young womanR Dickman, M Shaklai, M Lapidot, et al.
Cancer|June 1, 1996
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemiaS Shaklai, O Bairey, D Blickstein, et al.
International Journal of Oncology|May 14, 2011
Butyrate-induced differentiation in leukemic myeloid cells - in-vitro and in-vivo studiesA Rephaeli, J Nordenberg, A Aviram, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|February 21, 1992
Novel anticancer prodrugs of butyric acid. 2A Nudelman, M Ruse, A Aviram, et al.
Leukemia & Lymphoma|April 8, 1999
Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patientsA Aviram, D Blickstein, P Stark, et al.
British Journal of Cancer|June 28, 2002
Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphomaI Pazgal, Y Zimra, C Tzabar, et al.
The American Journal of Digestive Diseases|March 1, 1974
Intestinal lymphoma with unusual sequence of serum IgA changesM Shaklai, U Mintz, J Pinkhas, et al.
Scandinavian Journal of Haematology|April 1, 1982
Absence of predictive parameters for CNS involvement in adult non-lymphocytic leukaemia at time of diagnosisY Shoenfeld, M Rothenberg, S Berliner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cellsA Aviram, A Rephaeli, M Shaklai, et al.
Cancer|July 15, 1984
Monoclonal gammopathy in patients with chronic and acute myeloid leukemiaY Shoenfeld, S Berliner, A Ayalone, et al.
Journal of Clinical Gastroenterology|April 25, 2000
Pernicious anemia, gastric carcinoid, and autoimmune thrombocytopenia in a young womanR Dickman, M Shaklai, M Lapidot, et al.
Cancer|June 1, 1996
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemiaS Shaklai, O Bairey, D Blickstein, et al.
International Journal of Oncology|May 14, 2011
Butyrate-induced differentiation in leukemic myeloid cells - in-vitro and in-vivo studiesA Rephaeli, J Nordenberg, A Aviram, et al.
Pageof 15